1,411
Views
12
CrossRef citations to date
0
Altmetric
Perspective

Pandemic influenza vaccine & narcolepsy: simulations on the potential impact of bias

, , , , , , , , & show all
Pages 573-584 | Received 11 Dec 2015, Accepted 07 Mar 2016, Published online: 31 Mar 2016

References

  • National Institute for Health and Welfare (THL). National Institute for Health and Welfare recommends discontinuation of Pandemrix vaccinations. (Eds); 2010 Aug 25.
  • Medical Products Agency. The MPA investigates reports of narcolepsy in patients vaccinated with Pandemrix. (Eds); 2010.
  • European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP) Assessment report - Pandemrix Influenza vaccine (H1N1) (split virion, inactivated, adjuvanted) A/California/7/2009 (H1N1)v like strain (x-179a) - Procedure No.: EMEA/H/C/000832/A20/0045. (Eds); 2011 Jul 21.
  • European Medicines Agency. European Medicines Agency starts review of Pandemrix. (Eds); 2010 Aug 27.
  • European Medicines Agency. Press release: European Medicines Agency recommends restricting use of Pandemrix (Eds); 2011 Jul 21.
  • Kornum B, Faraco J, Mignot E. Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain. Curr Opin Neurobiol. 2011;21:897–903.
  • Nishino S, Ripley B, Overeem S, et al. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 2000;355(9197):39–40.
  • Overeem S, Black JL III, Lammers GJ. Narcolepsy: immunological aspects. Sleep Med Rev. 2008;12(2):95–107.
  • Luca G, Haba-Rubio J, Dauvilliers Y, et al. Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study. J Sleep Res. 2013;22(5):482–495.
  • Thorpy MJ, Krieger AC. Delayed diagnosis of narcolepsy: characterization and impact. Sleep Med. 2014;15(5):502–507.
  • Morrish E, King MA, Smith IE, et al. Factors associated with a delay in the diagnosis of narcolepsy. Sleep Med. 2004;5(1):37–41.
  • Singh AK, Mahlios J, Mignot E. Genetic association, seasonal infections and autoimmune basis of narcolepsy. J Autoimmun. 2013;43:26–31.
  • Medical Products Agency. Narcolepsy – Case inventory study in Sweden 2009–2010. (Eds); 2011.
  • Medical Products Agency. A registry based comparative cohort study in four Swedish counties of the risk for narcolepsy after vaccination with Pandemrix - A first and preliminary report, by the. (Eds); 2011.
  • European Centre for Disease Prevention and Control. Narcolepsy in association with pandemic influenza vaccination (a multi-country European epidemiological investigation). Stockholm: ECDC; 2012. (Eds).
  • Montplaisir J, Petit D, Quinn MJ, et al. Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. PLoS One. 2014;9(9):e108489.
  • Persson I, Granath F, Askling J, et al.. Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up. J Intern Med. 2014;275(2):172–190.
  • Nohynek H, Jokinen J, Partinen M, et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One. 2012;7(3):e33536.
  • Miller E, Andrews N, Stellitano L, et al. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. Bmj. 2013;346:f794.
  • Dauvilliers Y, Arnulf I, Lecendreux M, et al. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain J Neurol. 2013;136(Pt 8):2486–2496.
  • O’Flanagan D, Barret A, Foley M, et al. Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009-December 2010. Euro Surveill. 2014;19(17).
  • Barker CIS, Snape MD. Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action. Lancet Infect Dis. 2014;14(3):227–238.
  • Sturkenboom MC. The narcolepsy-pandemic influenza story: can the truth ever be unraveled? Vaccine. 2015;33(Suppl 2):B6–B13.
  • Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillain-Barre syndrome following vaccination in the national influenza immunization program, United States, 1976–1977. Am J Epidemiol. 1979;110(2):105–123.
  • Andrews N, Miller E, Taylor B, et al. Recall bias, MMR, and autism. Arch Dis Child. 2002;87(6):493–494.
  • Silber MH, Krahn LE, Olson EJ, et al. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep. 2002;25(2):197–202.
  • Mereckiene J, Cotter S, Weber JT, et al. Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe. Euro Surveill. 2012;17(4).
  • Lash TL, Fox MP, MacLehose RF, et al. Good practices for quantitative bias analysis. Int J Epidemiol. 2014;43(6):1969–1985.